XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Oct. 02, 2021
Sep. 26, 2020
Cash Flows from Operating Activities:    
Net income $ 10,402 $ 58,628
Non-cash items:    
Depreciation and amortization 48,567 41,603
Impairment of assets 5,144 1,028
Share-based compensation expense 12,807 12,119
Amortization of deferred finance costs 1,813 286
(Benefit) provision for losses on inventory 114 1,057
Gains on divestitures and sale of assets (9,603) (31,498)
Deferred tax benefit 898 (3,031)
Contingent consideration expense 9,345 0
Other non-cash operating activities 861 76
Amortization of fair value inventory step-up 5,295 0
Change in operating assets and liabilities:    
Change in accounts receivable (14,574) 22,391
Change in inventories (5,475) (38,189)
Change in prepaid income taxes 2,477 (635)
Change in other assets and other liabilities (842) 1,902
Change in accounts payable and accrued expenses (25,449) (24,770)
Net cash provided by operating activities 41,780 40,967
Cash Flows from Investing Activities:    
Capital expenditures (34,731) (16,035)
Acquisition (2,500) (16,606)
Proceeds from divestitures 0 44,978
Proceeds from sale of property, plant and equipment 860 902
Net cash (used in) provided by investing activities (36,371) 13,239
Cash Flows from Financing Activities:    
Net increase in short-term loans 0 90,000
Repayment of term loan borrowings (8,750) (8,750)
Proceeds from employee stock purchase plan 2,210 2,144
Proceeds from exercise of stock options 1,569 1,259
Other 22 (20)
Net cash (used in) provided by financing activities (4,949) 84,633
Effect of exchange rates on cash and cash equivalents (345) 3,019
Net Change in Cash and Cash Equivalents 115 141,858
Cash and Cash Equivalents at Beginning of Period 192,305 137,311
Cash and Cash Equivalents at End of Period 192,420 279,169
Supplemental Disclosures of Cash Flow Information:    
Transfers from inventory to fixed assets for placement of Haemonetics equipment $ 10,139 $ 4,203